$2.5B in R&D Funding for US Small Business

You are viewing an R&D grant awarded to a high-tech startup. The SBIR database contains more than 150,000 such awards as well as company and personnel profiles for the top researchers in virtually every emerging technology area.

$366K

DESCRIPTION (provided by applicant): This Phase II project continues the development and application of new materials, especially magnetic microparticles for directly isolating DNA from cells, tissues, and biological fluids, including whole blood, in an extremely rapid format. The materials eliminate the need to perform a lysis step and capture ...

$366K

DESCRIPTION (provided by applicant): This Phase II project continues the development and application of new materials, especially magnetic microparticles for directly isolating DNA from cells, tissues, and biological fluids, including whole blood, in an extremely rapid format. The materials eliminate the need to perform a lysis step and capture ...

$100K

DESCRIPTION (provided by applicant):
The objective of the proposed study is to develop new materials for the rapid isolation of nucleic acids from complex matrices such as whole blood. In Phase I we will prepare functionalized \microparticles for binding and releasing nucleic acids that utilize proprietary chemistry recently i developed at Lu...

$369K

DESCRIPTION (provided by applicant): Phase I of this proposal proved the feasibility of detection of the factor V Leiden mutation in human blood and correct determination of sample genotype as compared to a reference PCR method. The protocol used a new nucleic acid ligation-based technology, LMO amplification, invented at Lumigen. The LMO techno...

$369K

DESCRIPTION (provided by applicant): Phase I of this proposal proved the feasibility of detection of the factor V Leiden mutation in human blood and correct determination of sample genotype as compared to a reference PCR method. The protocol used a new nucleic acid ligation-based technology, LMO amplification, invented at Lumigen. The LMO techno...

$100K

The objective of Phase I is to prepare a new family of chemiluminescent label compounds which can be conjugated to proteins and nucleic acids, subjected to electrophoresis and triggered to generate chemiluminescence in the gel. Successful development of the labeling compounds will permit the development of simple methods for direct detection in ...

$96.2K

DESCRIPTION (Applicant's Abstract): The objective of Phase 1 is to develop a
sensitive test and kit for detection of the Factor V Leiden mutation in human
blood using a new nucleic acid ligation-based technology invented at Lumigen.
The ligation technology is based on the discovery that a multitude of short
oligonu...

Unknown

DESCRIPTION (Adapted from investigator's abstract): This project
proposes to demonstrate the feasibility of a novel multiplexed
chemiluminescent system for manual DNA sequencing or detection of
double-stranded DNA that can potentially replace the use of radioprobes
in small scale sequenci...

Unknown

The objective of Phase I is to develop simple, sensitive and unambiguous
chemiluminescent detection of juxtaposed genes in chromosomal
translocations associated with many cancers. We propose chemiluminescent
assay formats based on simultaneous probing and detection of both genes of
a translocation in a si...